How big is the Europe Nuclear Medicine Market?

The Europe Nuclear Medicine Market size is expected to reach USD 4.5 billion in 2024 and grow at a CAGR of 10% to reach USD 7.24 billion by 2029. Read More

What is the current Europe Nuclear Medicine Market size?

In 2024, the Europe Nuclear Medicine Market size is expected to reach USD 4.5 billion. Read More

Who are the key players in Europe Nuclear Medicine Market?

Cardinal Health, Curium Pharma, GE Healthcare, Novartis AG (Advanced Accelerator Applications) and Siemens Healthineers AG are the major companies operating in the Europe Nuclear Medicine Market. Read More

What years does this Europe Nuclear Medicine Market cover, and what was the market size in 2023?

In 2023, the Europe Nuclear Medicine Market size was estimated at USD 4.05 billion. The report covers the Europe Nuclear Medicine Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Europe Nuclear Medicine Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Europe Nuclear Medicine Market Share

Statistics for the 2023 & 2024 Europe Nuclear Medicine market share, created by Mordor Intelligence™ Industry Reports. Europe Nuclear Medicine share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Europe Nuclear Medicine Industry

The Europe Nuclear Medicine market is highly competitive, with the presence of a large number of players. There is high competition among the players in the global nuclear medicine market. Additionally, big players in the pharmaceutical and biotechnology industries are leveraging their huge capital reserves to venture into this market, further increasing the competition. Some of the major players in the market are Advanced Accelerator Applications, Bracco Imaging, Cardinal Health, Curium Pharma, GE Healthcare, Merck KGaA (Sigma-Aldrich), Nordion Inc., and Siemens Healthineers AG.